Epigenomics AG (FRA:ECX)

Market Cap	762.95K
Revenue (ttm)	4.00K
Net Income (ttm)	-2.76M
Shares Out	876.95K
EPS (ttm)	-3.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,800
Average Volume	576
Open	0.9020
Previous Close	0.9020
Day's Range	0.8700 - 0.9020
52-Week Range	0.5000 - 1.7000
Beta	0.76
RSI	45.03
Earnings Date	Mar 24, 2026

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ECX